RxDoctor Payments Data

Jaima Byrd

Psychiatric/Mental Health · Anderson, INNPI 1104472406

Payments from drug & device makers

$3,671in general payments, 2019–2025

Across 174 payments — averaging $21.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$518
  • Alkermes, Inc.$500
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$474
  • Supernus Pharmaceuticals, Inc.$428
  • AbbVie$377
  • Otsuka America Pharmaceutical, Inc.$307
  • plus $1K from 11 others

What the payments were for

  • Food & beverage$3,671100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,671 in reported general payments places this provider in the 85th percentile of 729 psychiatric/mental health providers in Indiana.

See all psychiatric/mental health providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole15$21,510
CaplytaLumateperone Tosylate12$19,197
VraylarCariprazine Hcl11$16,925
TrintellixVortioxetine Hydrobromide20$16,653
Ramelteon18$3,358
Aripiprazole28$2,748
Vilazodone Hcl11$1,552
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine19$1,049
Hydroxyzine Hcl39$805
Buspirone Hcl31$565
Doxepin Hcl26$553
Duloxetine Hcl22$494
Quetiapine Fumarate21$392
Propranolol Hcl29$340
Divalproex Sodium11$326

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$307$21,51015 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$474$19,19712 claims
AbbVieVraylar$377$16,92511 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$56$16,65320 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 729 psychiatric/mental health providers in Indiana.

Other psychiatric/mental health in Anderson

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →